The aim of Pincer Biotech is to ensure development of new clinical treatments based on frontline research regarding biofilms and persister cells in implant-associated infections conducted at Aarhus University and Aarhus University Hospital. The ultimate goal is to develop a new class of therapeutic compounds that address the critical issue of targeting the antibiotic-tolerant persister cells residing in the biofilm, thus overcoming the limitation that plagues all known antibiotics.